Advertisement
Screener

Rein Therapeutics, Inc. (RNTX) Form D

Rein Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-01-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-12-23; Total offering amount $40,000,000.
  • 2014-10-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-10-14; Total offering amount $32,999,999.
  • 2013-11-19: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2013-11-05; Total offering amount $30,000,000.
  • 2009-06-12: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2009-05-29; Total offering amount $40,150,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-01-06Rule 506(b)Equity2016-12-23$40,000,000$30,112,894$9,887,10611
2014-10-29Rule 506(b)Equity2014-10-14$32,999,999$19,799,999$13,200,00013
2013-11-19Rule 506(b)Equity2013-11-05$30,000,000$15,000,003$14,999,99711
2009-06-12Rule 506Equity2009-05-29$40,150,000$28,105,002$12,044,9988

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58